Navigation Links
Cord Blood America Enters Agreement With BancoVida, a Cord Blood Collection Company in San Juan, Puerto Rico
Date:8/29/2011

LAS VEGAS, Aug. 29, 2011 /PRNewswire/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI) announced today it has entered into an agreement with BancoVida (www.bancovida.com) to offer umbilical cord blood collection services in Puerto Rico and throughout the Caribbean.

The partnership will allow BancoVida and Cord Blood America to educate prospective parents in Puerto Rico and the Caribbean on the value of storing their baby's umbilical cord blood.  The stem cells will be stored at Cord Blood America's state-of-the-art facility in Las Vegas.

"We are very excited about our partnership with BancoVida and for the opportunity to assist them in bringing this potentially life-saving service to an underserved area," said Gabby Stinson, Cord Blood America Project Manager.

Cord blood stem cells, which are collected at birth in a non-invasive procedure, are currently used to treat more than 70 diseases including leukemia, severe anemia, metabolic blood disorders and immune deficiencies.  Various studies and clinical trials are currently underway to determine the effectiveness of stem cells in treating some of the most serious diseases, such as diabetes, heart disease, Parkinson's and cerebral palsy for which there is no known cure.

About BancoVida

BancoVida Corp. has been established to develop and market private cord blood banking services to patients in Puerto Rico and the Caribbean.  Our mission is to successfully introduce and become the leader of private cord blood banking in the Caribbean.  BancoVida is the exclusive reseller of cord blood banking services for Cord Blood America and CorCell in Puerto Rico and the Caribbean.  To find out more about BancoVida, visit our website at www.bancovida.com.  

About Cord Blood America

Cord Blood America (OTC Bulletin Board:  CBAI.ob) is the parent company of CorCell Companies, Inc., which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI.ob), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.

Paul Knopick
E & E Communications
pknopick@eandecommunications.com
949.707.5365


'/>"/>
SOURCE Cord Blood America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China Cord Blood Corporation to Report First Quarter Fiscal 2012 Financial Results
2. Cord Blood America Enters Agreement With Premera Blue Cross to Offer Member Discount on Stem Cell Collection Services
3. Cord Blood America Six Month Revenues Up 61 Percent; Gross Profit Up 100 Percent
4. Restoring blood flow
5. Parents Guide to Cord Blood Foundation Launches Nations First Searchable Map of U.S. Sites for Donating Umbilical Cord Blood
6. Making blood-sucking deadly for mosquitoes
7. Cord Blood America CEO Matthew Schissler Interviewed on International Successes
8. "Pure" Human Blood Stem-Cell Discovery Opens Door to Expanding Cells for More Clinical Use
9. CorCell, a Cord Blood America Company, Launches Referral Rewards Program
10. Cord Blood America Enters Agreement With Regence, Serving BlueCross and BlueShield Programs in the Northwest U.S. and Mountain Regions
11. Cord Blood America Enters Agreement With Horizon Healthcare Services, Inc. to Offer Stem Cell Collection Services to Its Members
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... NEW YORK , February 4, 2016 ... (OTCQB: QBIO), a biotechnology acceleration company is pleased to provide ... --> --> Over the last 3 months ... note and securities purchase agreements exceeding $1,000,000. As a result, ... under our Mannin Research Inc. license agreement and expect that ...
(Date:2/4/2016)... England , February 4, 2016 ... Bioscience Laboratories (ABL), Inc. --> Strasbourg, France ... Inc. --> PharmaVentures is pleased to announce that ... of its biopharmaceutical manufacturing unit in Strasbourg, France ... Inc. --> --> Transgene ...
(Date:2/3/2016)... , Feb. 3, 2016 Ascendis Pharma ... company that applies its innovative TransCon technology to address ... at an upcoming investor conference.Event:2016 Leerink Partners Global Healthcare ... Date:  , Wednesday, February 10, 2016 Time:  , ... www.ascendispharma.com . --> An audio webcast of ...
(Date:2/3/2016)... ... 03, 2016 , ... StarNet Communications Corp, ( http://www.starnet.com/ ) ... addition of a powerful “Session Preview” feature to its FastX remote Linux visualization ... remote Linux desktop or other applications (sessions) they have running on a remote ...
Breaking Biology Technology:
(Date:2/2/2016)... , Feb. 2, 2016  Based on its ... & Sullivan recognizes US-based Intelligent Retinal Imaging Systems ... Sullivan Award for New Product Innovation. IRIS, a ... North America , is poised to ... growing diabetic retinopathy market. The IRIS technology presents ...
(Date:1/27/2016)...  Rite Track, Inc. a leading semiconductor equipment and ... Ohio announced today the acquisition of PLUS LLC. ... Austin, Texas , will significantly bolster ... installations and technical support offerings for TEL Track Systems. ... "PLUS has provided world class service including refurbishment, enhancements ...
(Date:1/21/2016)... 21, 2016 --> ... market research report "Emotion Detection and Recognition Market by Technology ... (Facial Expression, Voice Recognition and Others), Services, Application ... to 2020", published by MarketsandMarkets, the global Emotion ... USD 22.65 Billion by 2020, at a CAGR ...
Breaking Biology News(10 mins):